ArticleDiabetes, obesity & metabolism2025

Analysis of patient characteristics and safety of insulin glargine U300 use in 21 359 patients with type-2 diabetes and chronic kidney disease: DPV registry study.

Anjaly Vijayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.